Yu‐Wen Su

1.5k total citations
44 papers, 1.2k citations indexed

About

Yu‐Wen Su is a scholar working on Molecular Biology, Complementary and alternative medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Yu‐Wen Su has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Complementary and alternative medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Yu‐Wen Su's work include Natural Compounds in Disease Treatment (5 papers), Alcohol Consumption and Health Effects (3 papers) and Barrier Structure and Function Studies (3 papers). Yu‐Wen Su is often cited by papers focused on Natural Compounds in Disease Treatment (5 papers), Alcohol Consumption and Health Effects (3 papers) and Barrier Structure and Function Studies (3 papers). Yu‐Wen Su collaborates with scholars based in China, United States and Taiwan. Yu‐Wen Su's co-authors include Ying-Chieh Tsai, Hassan Jumaa, Gary A. Koretzky, Yong Zhang, Jürgen Wienands, Michael Reth, Zhenzhou Jiang, Luyong Zhang, Yen-Wenn Liu and Chien‐Chih Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Immunity.

In The Last Decade

Yu‐Wen Su

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Yu‐Wen Su

Since Specialization

Citations

This map shows the geographic impact of Yu‐Wen Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Wen Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Wen Su more than expected).

Fields of papers citing papers by Yu‐Wen Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Wen Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Wen Su. The network helps show where Yu‐Wen Su may publish in the future.

Co-authorship network of co-authors of Yu‐Wen Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Wen Su. A scholar is included among the top collaborators of Yu‐Wen Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Wen Su. Yu‐Wen Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blood Metabolome Mediates the Effect of the Plasma Lipidome on the Risk of Atrial Fibrillation: A Mendelian Randomization Study 2025 ·Clinical Cardiology ·Yu‐Wen Su, Yi Ning, (unknown), (unknown)	0
2	Sijunzi decoction granules for the treatment of advanced refractory colorectal cancer: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial 2025 ·Frontiers in Medicine ·(unknown), Yu‐Wen Su, Lu Lu, (unknown), Zhi Jiang, Yangxian Xu, Tingting Wu, Yi Zhong, Hao Wu, Junming Chen, Ming Ruan, Lan Zheng, (unknown), Yabin Gong, Guang Ji, Hanchen Xu	1
3	Serum uric acid and its metabolism-a vital factor in the inflammatory transformation of cancer 2025 ·Journal of Advanced Research ·(unknown), Yu‐Wen Su, Hang Su, (unknown), (unknown), (unknown), (unknown), (unknown)	0
4	BMSC loaded photo-crosslinked hyaluronic acid/collagen hydrogel incorporating FG4592 for enhanced cell proliferation and nucleus pulposus differentiation 2024 ·International Journal of Biological Macromolecules ·Cheng‐Li Lin, Yu‐Wen Su, (unknown), Cheng‐Hsiang Kuo, Ting‐Yuan Tu, Jui‐Chen Tsai, (unknown)	9
5	Safety and immunogenicity of heterologous boosting with a bivalent SARS-CoV-2 mRNA vaccine (XBB.1.5/BQ.1) in Chinese participants aged 18 years or more: A randomised, double-blinded, active-controlled phase 1 trial 2024 ·Vaccine ·Yu‐Wen Su, (unknown), Yuanhui Wang, (unknown), (unknown), Qing Zhang, Chang Su, (unknown), (unknown), Yan Liu, (unknown), (unknown), Chunlei Li, Xiang Lü	3
6	Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database 2024 ·British Journal of Clinical Pharmacology ·(unknown), Tianyi Yang, Yuanhui Wang, Li Zhang, Ji Li, Yu‐Wen Su	1
7	Consecutive injections of low-dose interleukin-2 improve symptoms and disease control in patients with chronic spontaneous urticaria 2023 ·Clinical Immunology ·(unknown), Liting He, (unknown), Qing Liang, Jiang Li, Yixin Tan, Guiying Zhang, Yu‐Wen Su, Rong Xiao, Qianjin Lu, Hai Long	4
8	Constructing tungsten doping RuP2@Carbon dots for enhanced hydrogen evolution reaction in acidic and alkaline media 2023 ·International Journal of Hydrogen Energy ·Yingnan Jiang, Lingling Du, (unknown), Qi Zhang, Yu‐Wen Su, Meiling Sun, Guangchao Yin	13
9	Influence of Fixation and Permeabilization on the Mass Density of Single Cells: A Surface Plasmon Resonance Imaging Study 2019 ·Frontiers in Chemistry ·Ruoyu Cheng, Feng Zhang, Meng Li, (unknown), Yu‐Wen Su, Wei Wang	47
10	Hypoxia conditioning enhances neuroprotective effects of aged human bone marrow mesenchymal stem cell-derived conditioned medium against cerebral ischemia in vitro 2019 ·Brain Research ·Ying Zhang, (unknown), Yu‐Wen Su, Li Su, (unknown), Di Wu, Song Han, Junfa Li, (unknown), Sydney Corey, Cesar V. Borlongan, Xunming Ji	37
11	The telomerase inhibitor AZT enhances differentiation and prevents overgrowth of human pluripotent stem cell–derived neural progenitors 2018 ·Journal of Biological Chemistry ·Yao Hu, Kai-Heng Fang, Luping Shen, (unknown), Yuan Fang, Yu‐Wen Su, Min Xu, Yufeng Pan, Yaoyu Chen, Yan Liu	6
12	Surface plasmon resonance sensing: from purified biomolecules to intact cells 2018 ·Analytical and Bioanalytical Chemistry ·Yu‐Wen Su, Wei Wang	24
13	Interleukin-17 mediates triptolide-induced liver injury in mice 2014 ·Food and Chemical Toxicology ·Xinzhi Wang, Zhenzhou Jiang, (unknown), Jing Fu, Yu‐Wen Su, Lixin Sun, Luyong Zhang	43
14	Rasgrp2 regulates the permissiveness of NIH3T3 cells to a herpes simplex virus 1 mutant with inactivated ICP34.5 gene 2013 ·Acta Virologica ·Wei Xiao, Yu‐Wen Su, Shumin Zhou, (unknown), Guanghua He, (unknown), (unknown)	2
15	A Panel of Serum MicroRNAs as Specific Biomarkers for Diagnosis of Compound- and Herb-Induced Liver Injury in Rats 2012 ·PLoS ONE ·Yu‐Wen Su, Xi Chen, Zhenzhou Jiang, Tao Wang, Cheng Wang, Yun Zhang, Jing Wen, (unknown), Dan Zhu, Yue Zhang, Yijing Su, (unknown), Chen‐Yu Zhang, Luyong Zhang	61
16	Oral administration of Lactobacillus plantarum K68 ameliorates DSS-induced ulcerative colitis in BALB/c mice via the anti-inflammatory and immunomodulatory activities 2011 ·International Immunopharmacology ·Yen-Wenn Liu, Yu‐Wen Su, (unknown), Tzu-Hao Cheng, Ying-Chieh Tsai	108
17	Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down-regulating the MAPK, NF-κB and AP-1 signaling pathways 2011 ·International Immunopharmacology ·Yu‐Wen Su, Wen‐Fei Chiou, (unknown), (unknown), Chien‐Chih Chen, Ying-Chieh Tsai	133
18	Inhibitory Effects of Citronellol and Geraniol on Nitric Oxide and Prostaglandin E₂Production in Macrophages 2010 ·Planta Medica ·Yu‐Wen Su, (unknown), (unknown), (unknown), Ying-Chieh Tsai	71
19	LAT Links the Pre-BCR to Calcium Signaling 2003 ·Immunity ·Yu‐Wen Su, Hassan Jumaa	78
20	Interaction of SLP adaptors with the SH2 domain of Tec family kinases 1999 ·European Journal of Immunology ·Yu‐Wen Su, Yong Zhang, (unknown), Gary A. Koretzky, Michael Reth, Jürgen Wienands	198

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact